✦ LIBER ✦

An effective five-drug antiemetic combination for prevention of chemotherapy-related nausea and vomiting

✍ Scribed by John F. Kessler; David S. Alberts; Patricia M. Plezia; Vicki Wilson; Judy Chase; Matti Aapro; Earl A. Surwit

Publisher: Springer
Year: 1986
Tongue: English
Weight: 475 KB
Volume: 16
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00293993

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levonantradol, a new antiemetic with a h

Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy

✍ Rudolf A. Joss; Renato L. Galeazzi; Annakatharina Bischoff; Do D. Do; Aron Goldh 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 363 KB

A phase I study of a new 5HT3-receptor a

A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting

✍ Geoffrey Falkson; Adriaan J. Zyl 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 370 KB

In a phase I study of BRL43694A, a 5HT3-receptor antagonist, a single dose of 40 micrograms/kg was given to 24 patients. All patients received cytostatic treatment expected to cause nausea and vomiting. During the first 24 h, 12 patients were completely protected from nausea and vomiting, 4 experien

Phase 2 trial results with the novel neu

Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy

✍ Wichit Arpornwirat; Istvan Albert; Vincent L. Hansen; Jeremey Levin; Rajesh R. B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views